Attorney Articles December 14, 2017 View PDF Share The 2018 biosimilar litigation landscape: A primer YOU MAY ALSO BE INTERESTED IN Vous etes peut etre intéressé Sie könnten interessiert sein an Blog in Big Molecule Watch Amgen Moves to Dismiss and to Stay Regeneron’s Antitrust Case Blog in Big Molecule Watch Infliximab Clinical Trial Updates Blog in Big Molecule Watch Denosumab Clinical Trial Updates Stay Connected Subscribe to Goodwin Updates: Industry Alerts Blog Digests Firm Announcements Events + Webinars Sign Up for Goodwin Updates